RAP 0.00% 20.5¢ resapp health limited

Would appear FDA also already aware of CE for u guys....

  1. 6,155 Posts.
    lightbulb Created with Sketch. 2605
    Would appear FDA also already aware of CE for u guys.

    https://www.fdanews.com/articles/192516-resapp-gains-ce-mark-for-respiratory-disease-diagnostic-app
    FDAnews Device Daily Bulletin
    Medical Devices / Submissions and Approvals

    ResApp Gains CE Mark for Respiratory Disease Diagnostic App

    Aug. 28, 2019

    ResApp has earned the CE Mark for its ResAppDx-EU, a smartphone-based diagnostic test for acute pediatric respiratory disease.

    The CE Mark was supported by data from a pediatric clinical study showing that the app’s cough-based diagnosis algorithms had “excellent agreement with a clinical diagnosis,” the company said.

    The mobile software app is intended for use by clinicians to diagnose lower respiratory tract disease, croup, pneumonia, asthma/reactive airway disease and bronchiolitis in infants and children


 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.